Challenges in Treatment of Primary Sjögren's Syndrome and Opportunities for Chinese Medicine
Back to article page
Feature Article|Updated:2021-08-23
|
Challenges in Treatment of Primary Sjögren's Syndrome and Opportunities for Chinese Medicine
Chinese Journal of Integrative MedicineVol. 26, Issue 7, Pages: 483-485(2020)
Affiliations:
Department of Rheumatology and Immunology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai (200437), China
Jia-qi HOU, Luan XUE. Challenges in Treatment of Primary Sjögren's Syndrome and Opportunities for Chinese Medicine. [J]. Chinese Journal of Integrative Medicine 26(7):483-485(2020)
DOI:
Jia-qi HOU, Luan XUE. Challenges in Treatment of Primary Sjögren's Syndrome and Opportunities for Chinese Medicine. [J]. Chinese Journal of Integrative Medicine 26(7):483-485(2020) DOI: 10.1007/s11655-019-3226-0.
Challenges in Treatment of Primary Sjögren's Syndrome and Opportunities for Chinese Medicine
摘要
Abstract
Primary Sjögren's syndrome is a chronic autoimmune disease that can lead to systemic manifestations. At present
immunomodulatory agents have not shown good efficacy
many patients in China seek Chinese medicine treatment. Chinese medicine can comprehensively improve the symptoms of patients through Chinese pattern diagnosis and individualized treatment. Fundamental researches are providing scientific bases for the therapeutic effect of Chinese medicine. Professional Chinese medicine treatment can be integrated into the conventional management of primary Sjögren's syndrome.
关键词
Keywords
primary Sjögren's syndromeimmunomodulatory agentsChinese medicine
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice
TRAIL and Celastrol Combinational Treatment Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells via Targeting Wnt/β-Catenin Signaling Pathway
Related Author
No data
Related Institution
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Science, Xiamen University
Fujian Pien Tze Huang Enterprise Key Laboratory of Natural Medicine Research and Development
Department of General Surgery, First People's Hospital of Hangzhou Lin'an District
Institute of Chinese Medicine, The Chinese University of Hong Kong